thiophenes has been researched along with Restless Legs Syndrome in 80 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (20.00) | 29.6817 |
| 2010's | 61 (76.25) | 24.3611 |
| 2020's | 3 (3.75) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
| Chikahisa, S; Inoue, Y; Muramatsu, K; Séi, H; Shimizu, N | 1 |
| Aldawsari, HM; Alhakamy, NA; Gie, OA; Hooi, LC; Hosny, KM; Ian, N; Kang, AWC; Karim, S; Md, S; Saker, SR; Yee, PH; Zhe, CK | 1 |
| Barateau, L; Carlander, B; Chenini, S; Dauvilliers, Y; Guiraud, L; Jaussent, I; Lopez, R; Rassu, AL | 1 |
| Boura, I; Chaudhuri, KR; Jenner, P; Klingelhoefer, L; Leta, V; Raeder, V; Reichmann, H; Trenkwalder, C | 1 |
| Asgharnejad, M; Bauer, L; Benitez, A; Boroojerdi, B; Chung, SJ; Heidbrede, T; Kim, HJ; Little, A | 1 |
| Alghothani, L; Iftikhar, IH; Trotti, LM | 1 |
| Clemens, S; Dinkins, ML; Lallemand, P | 1 |
| Cano-Pumarega, I; Garcia-Borreguero, D; Marulanda, R | 1 |
| Chen, TY; Chen, YW; Hsu, CY; Lin, PY; Liou, LM; Tseng, PT; Wu, MN | 1 |
| Allen, RP; Högl, B; Inoue, Y; Oertel, W; Salminen, AV; Sampaio, C; Trenkwalder, C; Winkelman, JW; Winkelmann, J | 1 |
| Calviño, J; Cigarran, S; González-Tabares, L; Guijarro, M; Sobrido, MJ | 1 |
| Egawa, G; Kabashima, K; Nomura, T; Takeuchi, A | 1 |
| Bachmann, CG; Berg, D; Berkels, R; Grieger, F; Hofmann, WE; Lauterbach, T; Schollmayer, E; Stiasny-Kolster, K | 1 |
| Miranda C, M | 1 |
| Arth, C; Bauer, L; Brunnert, M; Elshoff, JP; Komenda, M; Schmid, M; Timmermann, L | 1 |
| Akbudak, M; Belli, H; Ural, C | 1 |
| Hattori, N; Hirata, K; Ikeda, J; Inoue, Y; Ishigooka, J; Oka, Y; Shimizu, T; Tomida, T; Uchimura, N | 1 |
| Allen, R; Benes, H; Grieger, F; Kohnen, R; Moran, K; Oertel, W; Schollmayer, E; Walters, A | 1 |
| Bogan, RK | 1 |
| Bassetti, CL; Ferini-Strambi, L; Fulda, S; Maestri, M; Manconi, M; Marelli, S; Staedler, C; Zucconi, M | 1 |
| Allen, RP | 1 |
| Toro, BE | 1 |
| Morel, T; Sun, Y; van Valkenhoef, G | 1 |
| Asgharnejad, M; Benitez, A; Edens, H; Fishman, J; Moran, K | 1 |
| Hadgraft, J; Lane, ME; McAfee, DA | 1 |
| Andreas, JO; Braun, M; Cawello, W; Elshoff, JP; Mathy, FX | 1 |
| Chen, HH; Ding, J; Fan, W; Sun, SG; Yan, P; Zheng, J | 1 |
| Jankovic, J; Wijemanne, S | 1 |
| Hattori, N; Hirata, K; Ikeda, J; Inoue, Y; Takahashi, M; Tomida, T | 1 |
| Grieger, F; Kohnen, R; Moran, K; Ondo, WG; Roth, T | 1 |
| Allen, R; Dohin, E; Garcia-Borreguero, D; Grieger, F; Hudson, J; Moran, K; Schollmayer, E; Smit, R; Winkelman, J | 1 |
| Benes, H; Dauvilliers, Y; Dohin, E; Goldammer, N; Partinen, M; Rauta, V; Rifkin, D; Schollmayer, E; Schröder, H; Winkelman, JW | 1 |
| Benes, H; Berkels, R; Canelo, M; Heidbrede, T; Kelling, D; Lang, M; Schollmayer, E; Schroeder, H; Trenkwalder, C | 1 |
| Bauer, A; Bauer, L; Benes, H; Carney, HC; Cassel, W; Grieger, F; Joeres, L; Kesper, K; Moran, K; Oertel, W; Rye, D; Schollmayer, E; Sica, D; Trenkwalder, C; Walters, AS; Whitesides, J; Winkelman, JW | 1 |
| Ferini-Strambi, L; Galbiati, A; Marelli, S | 1 |
| Garnock-Jones, KP | 1 |
| Jo, J; Mousa, SA; Sahli, ZT; Tarazi, FI | 1 |
| Mackie, SE; Mei, LA; Platt, S; Schoerning, L; Winkelman, JW | 1 |
| Allen, RP; Armstrong, MJ; Chaudhuri, KR; Gloss, D; Gronseth, GS; Ondo, W; Trenkwalder, C; Winkelman, JW; Zee, PC; Zesiewicz, T | 1 |
| Garcia-Borreguero, D | 1 |
| Sethi, KD | 1 |
| Benes, H; Chaudhuri, KR; de Weerd, AW; Ferini-Strambi, L; Garcia-Borreguero, D; Högl, B; Kohnen, R; Montagna, P; Odin, P; Oertel, WH; Partinen, M; Poewe, W; Schollmayer, E; Stiasny-Kolster, K; Trenkwalder, C | 1 |
| Benes, H; Garcia-Borreguero, D; Geisler, P; Högl, B; Kohnen, R; Oertel, WH; Schollmayer, E; Stiasny-Kolster, K; Tacken, I; Trenkwalder, C | 1 |
| Baldwin, CM; Keating, GM | 1 |
| Culebras, A; Kelly, JJ | 1 |
| Andreas, JO; Boekens, H; Braun, M; Cawello, W; Horstmann, R | 1 |
| Chen, JJ; Dashtipour, K; Lyons, KE; Swope, DM | 1 |
| Davies, S | 1 |
| Sixel-Döring, F; Trenkwalder, C | 1 |
| Reading, P | 1 |
| Allen, RP; Becker, P; Bogan, R; Fichtner, A; Fry, JM; Hening, WA; Kudrow, DB; Lesh, KW; Ondo, WG; Schollmayer, E; Walters, AS; Winkelman, JW | 1 |
| Boroojerdi, B; Braun, M; Scheller, DK; Wolff, HM | 1 |
| Benes, H; Cassel, W; Ferini-Strambi, L; Fichtner, A; Garcia-Borreguero, D; Högl, B; Kohnen, R; Montagna, P; Oertel, WH; Partinen, M; Penzel, T; Poewe, W; Polo, O; Saletu, B; Schollmayer, E; Sixel-Döring, F; Stiasny-Kolster, K; Trenkwalder, C | 1 |
| Beneš, H; García-Borreguero, D; Geisler, P; Högl, B; Kohnen, R; Oertel, WH; Poewe, W; Schollmayer, E; Stiasny-Kolster, K; Trenkwalder, C | 1 |
| Earley, CJ | 1 |
| Beneš, H; Ferini-Strambi, L; Fichtner, A; García-Borreguero, D; Högl, B; Kohnen, R; Oertel, W; Poewe, W; Schollmayer, E; Stiasny-Kolster, K; Trenkwalder, C | 1 |
| García-Borreguero, D; Oertel, W; Trenkwalder, C | 1 |
| Baumann, CR; Eisele, G; Gantenbein, AR; Schreglmann, SR | 1 |
| Calvo, E; de la Llave, Y; García-Borreguero, D; Granizo, JJ; Larrosa, O; Tzonova, D; Williams, AM | 1 |
| Beneš, H; Ferini-Strambi, L; Fichtner, A; García-Borreguero, D; Kohnen, R; Schollmayer, E | 1 |
| de la Fuente-Fernández, R | 1 |
| George, S; Jones, HB | 1 |
| de Biase, S; Gigli, GL; Lorenzut, S; Merlino, G; Valente, M | 1 |
| Bauer, L; Högl, B; Oertel, WH; Schollmayer, E | 1 |
| Dostal, M; Schaefer, C; Sobesky, J; Weber-Schoendorfer, C | 1 |
| Garcia-Borreguero, D; Hattori, N; Hayashida, K; Hirata, K; Inoue, Y; Tomida, T | 1 |
| Hensler, M; Lorenzl, S; Nübling, GS; Remi, J | 1 |
| Bauer, L; Dohin, E; Ferini-Strambi, L; Fichtner, A; García-Borreguero, D; Högl, B; Schollmayer, E | 1 |
| Chaudhuri, KR | 1 |
| Mucke, HA | 1 |
| Kohnen, R; Möller, JC; Oertel, WH; Schollmayer, E; Stiasny-Kolster, K | 1 |
| Zareba, G | 1 |
| Splinter, MY | 1 |
| Benes, H; Garcia-Borreguero, D; Geisler, P; Högl, B; Kohnen, R; Oertel, WH; Saletu, B; Schollmayer, E; Sommerville, KW; Stiasny-Kolster, K; Trenkwalder, C | 1 |
| Jankovic, J; Kenney, C | 1 |
28 review(s) available for thiophenes and Restless Legs Syndrome
| Article | Year |
|---|---|
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
Current Status and Challenges in Rotigotine Delivery.
Topics: Administration, Cutaneous; Dopamine Agonists; Humans; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2020 |
Rotigotine Transdermal Patch for Motor and Non-motor Parkinson's Disease: A Review of 12 Years' Clinical Experience.
Topics: Administration, Cutaneous; Dopamine Agonists; Humans; Parkinson Disease; Quality of Life; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2021 |
Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective.
Topics: Dopamine Agonists; Drug Substitution; Humans; Parkinson Disease; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2017 |
Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis.
Topics: Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Dopamine Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Pregabalin; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2017 |
Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
Topics: Dopamine; Dopamine Agonists; Drug Synergism; Humans; Quality of Life; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Failure | 2018 |
The efficacy and tolerability of rotigotine on patients with periodic limb movement in sleep: A systematic review and meta-analysis.
Topics: Humans; Nocturnal Myoclonus Syndrome; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2018 |
From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
Topics: Administration, Cutaneous; Dopamine Agonists; Drug Delivery Systems; Humans; PubMed; Restless Legs Syndrome; Sleep; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; United States; United States Food and Drug Administration | 2014 |
Restless legs syndrome/Willis Ekbom disease: evaluation and treatment.
Topics: Diagnosis, Differential; Dopamine Agonists; Humans; Mental Disorders; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2014 |
New treatment options for the management of restless leg syndrome.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Carbamates; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; gamma-Aminobutyric Acid; Guideline Adherence; Humans; Middle Aged; Nursing Diagnosis; Pregnancy; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Young Adult | 2014 |
Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Dopamine Agonists; Drug Delivery Systems; Humans; Parkinson Disease; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2014 |
Rotigotine: the first new chemical entity for transdermal drug delivery.
Topics: Administration, Cutaneous; Chemical Phenomena; Clinical Trials as Topic; Dopamine Agonists; Drug Delivery Systems; Humans; Molecular Structure; Parkinson Disease; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2014 |
An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome.
Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Comorbidity; Dopamine Agonists; Drug Interactions; Evidence-Based Medicine; Humans; Parkinson Disease; Practice Guidelines as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2015 |
Rotigotine in the treatment of primary restless legs syndrome: A meta-analysis of randomized placebo-controlled trials.
Topics: Humans; Placebos; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2015 |
Restless legs syndrome: clinical presentation diagnosis and treatment.
Topics: Amines; Analgesics, Opioid; Benzothiazoles; Cyclohexanecarboxylic Acids; Dopamine Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Methadone; Pramipexole; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2015 |
Clinical pharmacology and efficacy of rotigotine (Neupro® patch) in the treatment of restless leg syndrome.
Topics: Administration, Cutaneous; Animals; Dopamine Agonists; Drug Delivery Systems; Humans; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Time Factors; Transdermal Patch | 2016 |
Rotigotine Transdermal Patch: A Review in Restless Legs Syndrome.
Topics: Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Time Factors; Transdermal Patch; Treatment Outcome | 2016 |
Clinical management of restless legs syndrome in end-stage renal disease patients.
Topics: Amines; Analgesics, Opioid; Benzodiazepines; Benzothiazoles; Comorbidity; Cyclohexanecarboxylic Acids; Dopamine Agonists; Excitatory Amino Acid Antagonists; Exercise Therapy; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Intermittent Pneumatic Compression Devices; Kidney Failure, Chronic; Levodopa; Massage; Pramipexole; Quality of Life; Renal Dialysis; Restless Legs Syndrome; Sleep Hygiene; Tetrahydronaphthalenes; Thiophenes | 2017 |
Rotigotine transdermal patch: in restless legs syndrome.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Dopamine Agonists; Drug Tolerance; Humans; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2008 |
Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease.
Topics: Administration, Cutaneous; Animals; Antiparkinson Agents; Clinical Trials as Topic; Dopamine Agonists; Drug Interactions; Humans; Parkinson Disease; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2009 |
Rotigotine transdermal delivery for the treatment of restless legs syndrome.
Topics: Administration, Cutaneous; Dopamine Agonists; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2010 |
Treating restless legs syndrome with rotigotine.
Topics: Dopamine Agonists; Humans; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2010 |
Rotigotine transdermal patch for the treatment of Parkinson's disease and restless legs syndrome.
Topics: Administration, Cutaneous; Dopamine Agonists; Dosage Forms; Evidence-Based Medicine; Humans; Parkinson Disease; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2010 |
ADMET considerations for restless leg syndrome drug treatments.
Topics: Amines; Anticonvulsants; Benzothiazoles; Carbamates; Cyclohexanecarboxylic Acids; Dopamine Agents; Dopamine Agonists; Ergolines; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Levodopa; Neuralgia; Pramipexole; Pregabalin; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2012 |
Rotigotine Schwarz Pharma.
Topics: Animals; Clinical Trials as Topic; Dopamine Agonists; Drugs, Investigational; Humans; Parkinson Disease; Receptors, Dopamine D2; Restless Legs Syndrome; Technology, Pharmaceutical; Tetrahydronaphthalenes; Thiophenes | 2003 |
Rotigotine: a novel dopamine agonist for the transdermal treatment of Parkinson's disease.
Topics: Administration, Cutaneous; Animals; Dopamine Agonists; Humans; Parkinson Disease; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2006 |
Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Dopamine Agonists; Humans; Parkinson Disease; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2007 |
Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome.
Topics: Administration, Cutaneous; Dopamine Agonists; Humans; Parkinson Disease; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2007 |
24 trial(s) available for thiophenes and Restless Legs Syndrome
| Article | Year |
|---|---|
Increased Blood Pressure Dipping in Restless Legs Syndrome With Rotigotine: A Randomized Trial.
Topics: Adult; Aged; Blood Pressure; Dopamine Agonists; Double-Blind Method; Female; Humans; Middle Aged; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2020 |
Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany.
Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Germany; Humans; Levodopa; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Self Administration; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome | 2013 |
Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulations.
Topics: Adult; Biological Availability; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; Humans; Male; Parkinson Disease; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2013 |
Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study.
Topics: Aged; Asian People; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Restless Legs Syndrome; Severity of Illness Index; Sleep; Sleep Initiation and Maintenance Disorders; Tetrahydronaphthalenes; Thiophenes | 2013 |
Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.
Topics: Adult; Aged; Dopamine Agonists; Female; Humans; Male; Middle Aged; Quality of Life; Reproducibility of Results; Restless Legs Syndrome; Severity of Illness Index; Surveys and Questionnaires; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome; Young Adult | 2013 |
Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Delayed-Action Preparations; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Polysomnography; Pramipexole; Restless Legs Syndrome; Sleep Stages; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2014 |
Daytime symptoms of restless legs syndrome--clinical characteristics and rotigotine effectiveness.
Topics: Administration, Cutaneous; Adult; Aged; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2015 |
Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).
Topics: Adolescent; Adult; Aged; Dopamine Agonists; Double-Blind Method; Female; Humans; Internationality; Male; Middle Aged; Restless Legs Syndrome; ROC Curve; Severity of Illness Index; Surveys and Questionnaires; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome; Young Adult | 2016 |
Effects of rotigotine on daytime symptoms in patients with primary restless legs syndrome: a randomized, placebo-controlled study.
Topics: Adult; Aged; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2016 |
Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial.
Topics: Adolescent; Adult; Aged; Dopamine Agonists; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Young Adult | 2016 |
Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT.
Topics: Adolescent; Adult; Aged; Blood Pressure; Blood Pressure Determination; Dopamine Agonists; Double-Blind Method; Heart Rate; Humans; Least-Squares Analysis; Middle Aged; Nocturnal Myoclonus Syndrome; Photoperiod; Polysomnography; Restless Legs Syndrome; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome; Young Adult | 2016 |
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Analysis of Variance; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Restless Legs Syndrome; Retrospective Studies; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2008 |
One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome.
Topics: Administration, Cutaneous; Adult; Aged; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Restless Legs Syndrome; Severity of Illness Index; Surveys and Questionnaires; Tetrahydronaphthalenes; Thiophenes; Young Adult | 2008 |
Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopa.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Area Under Curve; Carbidopa; Dopamine Agents; Dopamine Agonists; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2009 |
Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States.
Topics: Adolescent; Adult; Aged; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Restless Legs Syndrome; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome; United States; Young Adult | 2010 |
Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Movement; Polysomnography; Restless Legs Syndrome; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome; Young Adult | 2010 |
Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch.
Topics: Adult; Aged; Dopamine Agonists; Female; Humans; Male; Middle Aged; Patient Compliance; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Young Adult | 2010 |
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Headache; Humans; Male; Middle Aged; Nasopharyngitis; Prospective Studies; Restless Legs Syndrome; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; Time Factors; Transdermal Patch; Treatment Outcome; Young Adult | 2011 |
The powerful pre-treatment effect: placebo responses in restless legs syndrome trials.
Topics: Adolescent; Adult; Aged; Bias; Dopamine Agonists; Female; Humans; Male; Middle Aged; Placebo Effect; Research Design; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Young Adult | 2012 |
Transdermal rotigotine for the perioperative management of restless legs syndrome.
Topics: Administration, Cutaneous; Aged; Female; Humans; Male; Middle Aged; Paralysis, Hyperkalemic Periodic; Perioperative Period; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2012 |
Efficacy, safety and risk of augmentation of rotigotine for treating restless legs syndrome.
Topics: Adult; Aged; Asian People; Dopamine Agonists; Female; Humans; Male; Middle Aged; Restless Legs Syndrome; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2013 |
Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 - 3 mg/24 h for up to 5 years.
Topics: Administration, Cutaneous; Adult; Aged; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; International Cooperation; Male; Middle Aged; Prospective Studies; Restless Legs Syndrome; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome | 2013 |
Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Dopamine Agonists; Double-Blind Method; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Pilot Projects; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2004 |
Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe.
Topics: Administration, Cutaneous; Adult; Aged; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Female; Humans; Male; Middle Aged; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2008 |
28 other study(ies) available for thiophenes and Restless Legs Syndrome
| Article | Year |
|---|---|
Rotigotine suppresses sleep-related muscle activity augmented by injection of dialysis patients' sera in a mouse model of restless legs syndrome.
Topics: Animals; Case-Control Studies; Disease Models, Animal; Dopamine Agonists; Humans; Kidney Failure, Chronic; Male; Mice; Mice, Knockout; Muscles; Musculoskeletal Physiological Phenomena; Nerve Tissue Proteins; Renal Dialysis; Restless Legs Syndrome; Serum; Sleep, REM; Tetrahydronaphthalenes; Thiophenes | 2019 |
Long-term treatment with dopamine D3 receptor agonists induces a behavioral switch that can be rescued by blocking the dopamine D1 receptor.
Topics: Animals; Benzazepines; Benzothiazoles; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Male; Mice, Inbred C57BL; Pain Threshold; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D3; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2017 |
Reply to: A note on rotigotine for restless legs syndrome after renal transplantation.
Topics: Humans; Kidney Transplantation; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2019 |
A note on rotigotine for restless legs syndrome after renal transplantation.
Topics: Humans; Kidney Transplantation; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2019 |
Contact leukoderma induced by rotigotine transdermal patch (Neupro®).
Topics: Dopamine Agonists; Female; Humans; Hypopigmentation; Middle Aged; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2019 |
[Transdermal Rotigotine in the treatment of restless legs patients who develop augmentation of symptoms].
Topics: Administration, Cutaneous; Aged; Disease Progression; Dopamine Agonists; Female; Humans; Male; Middle Aged; Restless Legs Syndrome; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes | 2013 |
Duloxetine-related galactorrhea and restless legs syndrome: a case report.
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Galactorrhea; Humans; Middle Aged; Restless Legs Syndrome; Thiophenes | 2013 |
A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
Topics: Adult; Aged; Bayes Theorem; Benzothiazoles; Carbamates; Dopamine Agonists; Female; gamma-Aminobutyric Acid; Humans; Indoles; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2014 |
Transdermal rotigotine in restless legs syndrome: impulse control disorders.
Topics: Administration, Cutaneous; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Restless Legs Syndrome; Risk Assessment; Risk Factors; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome | 2014 |
Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational study.
Topics: Adult; Aged; Dopamine Agonists; Female; Humans; Male; Middle Aged; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2017 |
A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
Topics: Administration, Oral; Aged; Benzothiazoles; Dopamine Agonists; Drug Synergism; Female; Humans; Indoles; Male; Pramipexole; Restless Legs Syndrome; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; Time Factors; Transdermal Patch | 2016 |
Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Topics: Adult; Dopamine Agents; Dopamine Agonists; Humans; Practice Guidelines as Topic; Restless Legs Syndrome; Societies, Medical; Tetrahydronaphthalenes; Thiophenes | 2016 |
Restless legs syndrome (Willis-Ekbom disease): an urgent need for better treatments.
Topics: Humans; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2017 |
Restless legs syndrome sees the light of day.
Topics: Dopamine Agonists; Humans; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2008 |
Sleep disorders and neuromuscular diseases.
Topics: Administration, Cutaneous; Brain Injuries; Continuous Positive Airway Pressure; Copper; Diabetic Neuropathies; Dopamine Agonists; Humans; Ischemic Attack, Transient; Myasthenia Gravis; Neuromuscular Diseases; Peripheral Nervous System Diseases; Restless Legs Syndrome; Sleep Apnea Syndromes; Sleep Wake Disorders; Stroke; Tetrahydronaphthalenes; Thiophenes | 2008 |
Rotigotine and restless legs syndrome: new indication. The worst dopamine agonist. Just as unsatisfactory; defective design.
Topics: Administration, Cutaneous; Dopamine Agonists; Europe; Humans; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2009 |
Rotigotine for restless legs syndrome.
Topics: Administration, Cutaneous; Dopamine Agonists; Dosage Forms; Drug Evaluation, Preclinical; Humans; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2009 |
[Pharmacology sheet. Transdermal Rotigotine (Neupro)].
Topics: Administration, Cutaneous; Antiparkinson Agents; Dopamine Agonists; Humans; Parkinson Disease; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2010 |
Another dopamine agonist for treatment of restless legs syndrome.
Topics: Administration, Cutaneous; Dopamine Agonists; Humans; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2011 |
Treatment of restless legs syndrome with rotigotine.
Topics: Dopamine Agonists; Humans; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2011 |
Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Longitudinal Studies; Male; Middle Aged; Restless Legs Syndrome; Retrospective Studies; Surveys and Questionnaires; Tetrahydronaphthalenes; Thiophenes | 2012 |
Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease).
Topics: Adult; Aged; Benzothiazoles; Circadian Rhythm; Clonazepam; Cross-Sectional Studies; Dopamine Agonists; Female; GABA Modulators; Health Surveys; Humans; Indoles; Male; Middle Aged; Pramipexole; Prevalence; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2012 |
Augmentation in the treatment of restless legs syndrome with transdermal rotigotine.
Topics: Administration, Cutaneous; Controlled Clinical Trials as Topic; Dopamine Agonists; Dose-Response Relationship, Drug; Europe; Humans; Restless Legs Syndrome; Retrospective Studies; Risk Factors; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; United States | 2012 |
'You never told me I would turn into a gambler': a first person account of dopamine agonist--induced gambling addiction in a patient with restless legs syndrome.
Topics: Cabergoline; Carbidopa; Cognitive Behavioral Therapy; Dopamine Agonists; Drug Combinations; Ergolines; Gambling; Humans; Indoles; Levodopa; Male; Middle Aged; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2011 |
In brief: transdermal rotigotine (Neupro).
Topics: Antiparkinson Agents; Parkinson Disease; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2012 |
Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series.
Topics: Dopamine Agonists; Female; Humans; Indoles; Levodopa; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2013 |
Prospective evaluation of the frequency and treatment of restless legs syndrome in a palliative care unit.
Topics: Aged; Dopamine Agonists; Female; Hospital Units; Humans; Male; Middle Aged; Neoplasms; Palliative Care; Prospective Studies; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2012 |
Restless legs syndrome.
Topics: Apomorphine; Cabergoline; Dopamine Agonists; Ergolines; Europe; Humans; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2003 |